相关实验视频

Updated: Jan 10, 2026

Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction

Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction

Published on: April 14, 2022

抗HMGCR+和抗SRP+免疫媒介性死肌病自身抗体对工程肌肉功能的补充独立的病原性影响

Heta Lad^1,2, Yekaterina Tiper^1,2, Ernest Myguel Esteban^1,2

¹Institute of Biomedical Engineering, University of Toronto, Toronto, ON, M5S3G9, Canada.

Skeletal muscle

|November 25, 2025

概括

患有免疫媒介性死肌病 (IMNM) 的患者自身抗体可以直接损害肌肉功能. 这项研究表明,IMNM患者的免疫球蛋白 (IgG) 进入肌肉细胞并减少收缩力,独立于补体激活.

科学领域:

免疫学免疫学免疫学
肌肉生物学肌肉生物学
这是一种自身免疫力.

背景情况:

免疫媒介性死性肌肉病变 (IMNM) 的特征是具有特定的自身抗体 (抗SRP或抗HMGCR).
这些自身抗体对骨肌肉力量的直接影响,与补体激活分开,尚不清楚.

研究的目的:

调查IMNM患者自身抗体对骨肌肉收缩力的直接致病作用.
为了确定自身抗体是否可以进入肌肉细胞并影响功能,独立于补体系统.

主要方法:

使用3D人类骨肌微组织 (hMMT) 平台来评估收缩功能.
用IMNM患者 (抗SRP+或抗HMGCR+) 的免疫球蛋白 (IgG) 治疗的hMMT和2D肌管,在补充无活化或补充介质中.
通过显微镜评估力量生成,收缩动力学和IgG内部化.

主要成果:

来自IMNM患者子集的IgG减少了hMMT收缩力,并减缓了收缩/放松率.
在IgG暴露后,肉瘤结构表现出脆弱的迹象.
细胞内IgG染色证实了自身抗体进入肌肉细胞,即使没有补体激活.
抗HMGCR+IgG显示病原性影响的频率更高.

结论:

患者衍生的IgG可以进入肌肉细胞并直接损害缩功能,而不依赖于补充.
这些发现支持开发基于直接抗体效应的IMNM向疗法.

关键词:

自动抗体是一种自身抗体.补充补充补充补充疾病建模疾病建模免疫介导的死性肌肉病变.骨肌肉缩骨肌肉缩刺激的收缩力刺激的收缩力.

更多相关视频

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

Immunolabelling Myofiber Degeneration in Muscle Biopsies

Immunolabelling Myofiber Degeneration in Muscle Biopsies

Published on: December 5, 2019

相关概念视频

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...